• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中的代谢性酸中毒:发病机制、临床后果及治疗

Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment.

作者信息

Kim Hyo Jin

机构信息

Department of Internal Medicine, Pusan National University School of Medicine, Busan, Republic of Korea.

Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.

出版信息

Electrolyte Blood Press. 2021 Dec;19(2):29-37. doi: 10.5049/EBP.2021.19.2.29. Epub 2021 Dec 23.

DOI:10.5049/EBP.2021.19.2.29
PMID:35003283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8715222/
Abstract

The kidneys play an important role in regulating the acid-base balance. Metabolic acidosis is common in chronic kidney disease (CKD) patients and can lead to poor outcomes, such as bone demineralization, muscle mass loss, and worsening of renal function. Metabolic acidosis is usually approached with evaluating the serum bicarbonate levels but should be assessed by counting blood pH. Current guidelines recommend oral bicarbonate supplementation to maintain the serum bicarbonate levels within the normal range. However, a slow decline in the glomerular filtration rate might occur, even though the serum bicarbonate levels were in the normal range. Because the serum bicarbonate levels decrease when metabolic acidosis advances, other biomarkers are necessary to indicate acid retention for early diagnosis of metabolic acidosis. For this, urine citrate and ammonium excretion may be used to follow the course of CKD patients. Metabolic acidosis can be treated with an increased fruit and vegetable intake and oral alkali supplementation. Previous studies have suggested that administration of oral sodium bicarbonate may preserve kidney function without significant increases in blood pressure and body weight. Veverimer, a non-absorbed, counterion-free, polymeric drug, is emerging to treat metabolic acidosis, but further researches are awaited. Further studies are also needed to clarify the target therapeutic range of serum bicarbonate and the drugs used for metabolic acidosis.

摘要

肾脏在调节酸碱平衡中发挥着重要作用。代谢性酸中毒在慢性肾脏病(CKD)患者中很常见,并且会导致不良后果,如骨质脱矿、肌肉量减少以及肾功能恶化。代谢性酸中毒通常通过评估血清碳酸氢盐水平来处理,但应通过测量血液pH值进行评估。当前指南建议口服补充碳酸氢盐以将血清碳酸氢盐水平维持在正常范围内。然而,即使血清碳酸氢盐水平处于正常范围,肾小球滤过率仍可能缓慢下降。由于代谢性酸中毒进展时血清碳酸氢盐水平会降低,因此需要其他生物标志物来指示酸潴留,以便早期诊断代谢性酸中毒。为此,尿枸橼酸盐和铵排泄可用于追踪CKD患者的病程。代谢性酸中毒可通过增加水果和蔬菜摄入量以及口服碱补充剂来治疗。先前的研究表明,口服碳酸氢钠给药可能在不显著增加血压和体重的情况下保护肾功能。维维美林是一种不被吸收、无抗衡离子的聚合物药物,正在兴起用于治疗代谢性酸中毒,但尚待进一步研究。还需要进一步研究以明确血清碳酸氢盐的目标治疗范围以及用于治疗代谢性酸中毒的药物。

相似文献

1
Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment.慢性肾脏病中的代谢性酸中毒:发病机制、临床后果及治疗
Electrolyte Blood Press. 2021 Dec;19(2):29-37. doi: 10.5049/EBP.2021.19.2.29. Epub 2021 Dec 23.
2
[Electrolyte and acid-base balance disorders in advanced chronic kidney disease].[晚期慢性肾脏病中的电解质和酸碱平衡紊乱]
Nefrologia. 2008;28 Suppl 3:87-93.
3
Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.维维美尼与安慰剂在代谢性酸中毒合并慢性肾脏病患者中的比较:一项多中心、随机、双盲、对照、3 期临床试验。
Lancet. 2019 Apr 6;393(10179):1417-1427. doi: 10.1016/S0140-6736(18)32562-5. Epub 2019 Mar 8.
4
Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease.Veverimer 的作用机制:一种新型的、口服的、不被吸收的、无抗衡离子的盐酸结合剂,正在开发用于治疗慢性肾脏病中的代谢性酸中毒。
J Pharmacol Exp Ther. 2020 Dec;375(3):439-450. doi: 10.1124/jpet.120.000190. Epub 2020 Oct 8.
5
Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study.碳酸氢盐对伴有和不伴有 CKD 患者净酸排泄、血压和代谢的影响:CKD 中的酸碱补偿研究。
Am J Kidney Dis. 2021 Jul;78(1):38-47. doi: 10.1053/j.ajkd.2020.10.015. Epub 2021 Mar 31.
6
Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.用水果和蔬菜或口服碳酸氢盐治疗 3 期慢性肾脏病患者的代谢性酸中毒可减少尿血管紧张素原并维持肾小球滤过率。
Kidney Int. 2014 Nov;86(5):1031-8. doi: 10.1038/ki.2014.83. Epub 2014 Apr 2.
7
Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.尿枸橼酸排泄作为无显性代谢性酸中毒的慢性肾脏病患者酸保留的标志物。
Kidney Int. 2019 May;95(5):1190-1196. doi: 10.1016/j.kint.2018.11.033. Epub 2019 Mar 1.
8
Effects of veverimer on serum bicarbonate and physical function in diabetic patients with chronic kidney disease and metabolic acidosis: subgroup analysis from a randomized, controlled trial.维瓦雷默对合并代谢性酸中毒的慢性肾脏病糖尿病患者血清碳酸氢盐和体力功能的影响:一项随机对照试验的亚组分析。
Nephrol Dial Transplant. 2022 Jun 23;37(7):1302-1309. doi: 10.1093/ndt/gfab209.
9
Metabolic Acidosis in CKD: Core Curriculum 2019.慢性肾脏病代谢性酸中毒:2019 年核心课程。
Am J Kidney Dis. 2019 Aug;74(2):263-275. doi: 10.1053/j.ajkd.2019.01.036. Epub 2019 Apr 26.
10
Metabolic Acidosis of CKD: An Update.慢性肾脏病相关代谢性酸中毒:更新。
Am J Kidney Dis. 2016 Feb;67(2):307-17. doi: 10.1053/j.ajkd.2015.08.028. Epub 2015 Oct 23.

引用本文的文献

1
Chronic kidney disease in the primary care setting: A narrative review.基层医疗环境中的慢性肾脏病:一篇叙述性综述。
J Gen Fam Med. 2025 Jul 29;26(5):385-393. doi: 10.1002/jgf2.70054. eCollection 2025 Sep.
2
Metabolic Acidosis in Patients with Chronic Kidney Disease: Diagnosis, Pathogenesis, and Treatment-A Narrative Review.慢性肾脏病患者的代谢性酸中毒:诊断、发病机制及治疗——一篇叙述性综述
Diagnostics (Basel). 2025 Aug 15;15(16):2052. doi: 10.3390/diagnostics15162052.
3
Effects of microplastics on the bones: a comprehensive review.微塑料对骨骼的影响:综述
Osteoporos Int. 2025 Jun 24. doi: 10.1007/s00198-025-07580-4.
4
Critical Review of the Benefit from Early Pharmacological and Dietary Support for Patients with Moderate-to-Severe (Non-Terminal) Chronic Kidney Disease.对中重度(非终末期)慢性肾病患者早期药物和饮食支持益处的批判性综述
Biomedicines. 2025 Apr 19;13(4):994. doi: 10.3390/biomedicines13040994.
5
Realistic Albumin Concentrations in Virtual Subjects Across A Spectrum of Renal Function to Account for Variability in Protein Binding Within PBPK Models.虚拟受试者中跨一系列肾功能的实际白蛋白浓度,以考虑生理药代动力学(PBPK)模型内蛋白质结合的变异性。
AAPS J. 2025 Apr 26;27(4):82. doi: 10.1208/s12248-025-01062-5.
6
Metabolic and Pharmacokinetic Profiling of a Ketone Ester by Background SGLT2 Inhibitor Therapy in HFrEF.在射血分数降低的心力衰竭(HFrEF)中,通过背景钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂治疗对酮酯进行代谢和药代动力学分析。
JACC Basic Transl Sci. 2025 Mar;10(3):290-303. doi: 10.1016/j.jacbts.2024.10.014. Epub 2024 Nov 15.
7
Veverimer, a Nonabsorbed Gastrointestinal Tract HCl Binder, Decreases Renal Ammoniagenesis and Mitigates Nephrotoxic Serum Nephritis.维维利默,一种不被吸收的胃肠道盐酸结合剂,可减少肾脏氨生成并减轻肾毒性血清肾炎。
Kidney360. 2025 May 1;6(5):696-706. doi: 10.34067/KID.0000000743. Epub 2025 Mar 3.
8
Cultivating Innovative, Pragmatic, Randomized Controlled Registry Trials Embedded in Hemodialysis Care: Conference Proceeding From Gardener's Grove 2023.培养嵌入血液透析护理的创新、务实、随机对照注册试验:2023年园丁谷会议论文集
Can J Kidney Health Dis. 2025 Feb 14;12:20543581251318442. doi: 10.1177/20543581251318442. eCollection 2025.
9
The effect of renal function on the clinical outcomes and management of patients hospitalized with hyperglycemic crises.肾功能对高血糖危象住院患者临床结局及治疗的影响。
Front Endocrinol (Lausanne). 2025 Jan 9;15:1445040. doi: 10.3389/fendo.2024.1445040. eCollection 2024.
10
Hyperkalemia management: a multidisciplinary expert panel's perspective on the role of new potassium binders.高钾血症的管理:多学科专家小组对新型钾结合剂作用的观点
Heart Fail Rev. 2025 Mar;30(2):271-286. doi: 10.1007/s10741-024-10461-3. Epub 2024 Nov 27.

本文引用的文献

1
Nutritional Approaches for the Management of Metabolic Acidosis in Chronic Kidney Disease.营养治疗用于慢性肾脏病代谢性酸中毒的管理。
Nutrients. 2021 Jul 24;13(8):2534. doi: 10.3390/nu13082534.
2
Metabolic Acidosis Is an Independent Risk Factor of Renal Progression in Korean Chronic Kidney Disease Patients: The KNOW-CKD Study Results.代谢性酸中毒是韩国慢性肾脏病患者肾脏疾病进展的独立危险因素:韩国慢性肾脏病队列研究(KNOW-CKD)结果
Front Med (Lausanne). 2021 Jul 29;8:707588. doi: 10.3389/fmed.2021.707588. eCollection 2021.
3
Assessment of Acid-Base Status: Beyond Serum Bicarbonate.酸碱状态评估:超越血清碳酸氢盐
Clin J Am Soc Nephrol. 2021 Sep;16(9):1429-1431. doi: 10.2215/CJN.02760221. Epub 2021 Jun 4.
4
Metabolic Acidosis in CKD: A Review of Recent Findings.慢性肾脏病中的代谢性酸中毒:近期研究结果综述
Kidney Med. 2021 Feb 10;3(2):267-277. doi: 10.1016/j.xkme.2020.12.006. eCollection 2021 Mar-Apr.
5
Relationship between serum total carbon dioxide concentration and bicarbonate concentration in patients undergoing hemodialysis.血液透析患者血清总二氧化碳浓度与碳酸氢盐浓度之间的关系。
Kidney Res Clin Pract. 2020 Dec 31;39(4):441-450. doi: 10.23876/j.krcp.19.126.
6
Metabolic Acidosis and CKD Progression.代谢性酸中毒与慢性肾脏病进展
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):310-312. doi: 10.2215/CJN.07990520. Epub 2020 Aug 7.
7
Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial.口服碳酸氢钠治疗老年慢性肾脏病合并轻度酸中毒患者的临床效果和成本效益(BiCARB):一项实用随机、双盲、安慰剂对照试验。
BMC Med. 2020 Apr 9;18(1):91. doi: 10.1186/s12916-020-01542-9.
8
Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.代谢性酸中毒导致慢性肾脏病肾损伤的机制。
J Am Soc Nephrol. 2020 Mar;31(3):469-482. doi: 10.1681/ASN.2019070677. Epub 2020 Jan 27.
9
Sodium Bicarbonate Supplementation and Urinary TGF-1 in Nonacidotic Diabetic Kidney Disease: A Randomized, Controlled Trial.碱化剂补充碳酸氢钠和非酸中毒性糖尿病肾病患者的尿转化生长因子-β1:一项随机对照试验。
Clin J Am Soc Nephrol. 2020 Feb 7;15(2):200-208. doi: 10.2215/CJN.06600619. Epub 2020 Jan 23.
10
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial.一项比较两种剂量碳酸氢钠在 CKD 中的安全性、依从性和药效学特征的随机试验:BASE 试验。
J Am Soc Nephrol. 2020 Jan;31(1):161-174. doi: 10.1681/ASN.2019030287. Epub 2019 Dec 17.